Trial NCT02298166

View at ClinicalTrials.gov 
Org. Study IDs: AMLSG 19-13 / ARO-007

Last trial update was posted on 2021-10-06

MeSH Interventions

Crenolanib Cytarabine Mitoxantrone

MeSH Conditions

Leukemia Leukemia, Myeloid Leukemia, Myeloid, Acute

Other Conditions

Acute Myeloid Leukemia

Stopping Reasons

The manufacturer Arog Pharmaceuticals Inc has terminated the Agreement Concerning the Support of an Investigator Initiated Trial this became valid on 2020/03/09

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID